Clinical Trial

Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated February 25, 2026 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to determine the safety and potential of dendritic cells therapy and secretomes therapy for advanced nasopharyngeal cancer.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-02-20; most recent amendment 2026-02-23.
Status change: Recruiting → Active, Not Recruiting 2026-02-23
Status change: Not Yet Recruiting → Recruiting 2022-09-23
Trial Details
NCT Number NCT05261750
Lead Sponsor PT. Prodia Stem Cell Indonesia
Conditions Nasopharyngeal Cancer
Enrollment 15 participants
Start Date 2022-04-30
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-02-25